These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31945451)

  • 1. A new cocrystal of isoniazid-quercetin with hepatoprotective effect: The design, structure, and in vitro/in vivo performance evaluation.
    Liu F; Wang LY; Yu MC; Li YT; Wu ZY; Yan CW
    Eur J Pharm Sci; 2020 Mar; 144():105216. PubMed ID: 31945451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocrystallization with syringic acid presents a new opportunity for effectively reducing the hepatotoxicity of isoniazid.
    Liu F; Jiang FB; Li YT; Liu RM; Wu ZY; Yan CW
    Drug Dev Ind Pharm; 2020 Jun; 46(6):988-995. PubMed ID: 32366135
    [No Abstract]   [Full Text] [Related]  

  • 3. Quercetin attenuates NLRP3 inflammasome activation and apoptosis to protect INH-induced liver injury via regulating SIRT1 pathway.
    Zhang Y; Qu X; Gao H; Zhai J; Tao L; Sun J; Song Y; Zhang J
    Int Immunopharmacol; 2020 Aug; 85():106634. PubMed ID: 32492628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Stability of Tuberculosis Drug Fixed-Dose Combination Using Isoniazid-Caffeic Acid and Vanillic Acid Cocrystal.
    Battini S; Mannava MKC; Nangia A
    J Pharm Sci; 2018 Jun; 107(6):1667-1679. PubMed ID: 29462633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoprotective effect of Anacyclus pyrethrum Linn. against antitubercular drug-induced hepatotoxicity in SD rats.
    Usmani A; Mujahid M; Khushtar M; Siddiqui HH; Rahman MA
    J Complement Integr Med; 2016 Sep; 13(3):295-300. PubMed ID: 27101559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocrystal of Apixaban-Quercetin: Improving Solubility and Bioavailability of Drug Combination of Two Poorly Soluble Drugs.
    Zhang L; Kong D; Wang H; Jiao L; Zhao X; Song J; Yang D; Yang H; Yang S; Du G; Lu Y
    Molecules; 2021 May; 26(9):. PubMed ID: 34063645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin protected against isoniazide-induced HepG2 cell apoptosis by activating the SIRT1/ERK pathway.
    Zhang Y; Zhang W; Tao L; Zhai J; Gao H; Song Y; Qu X
    J Biochem Mol Toxicol; 2019 Sep; 33(9):e22369. PubMed ID: 31332904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.
    Hearn MJ; Cynamon MH
    J Antimicrob Chemother; 2004 Feb; 53(2):185-91. PubMed ID: 14688045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid Bactericidal Activity Involves Electron Transport Chain Perturbation.
    Zeng S; Soetaert K; Ravon F; Vandeput M; Bald D; Kauffmann JM; Mathys V; Wattiez R; Fontaine V
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective role of quercetin against manganese-induced injury in the liver, kidney, and lung; and hematological parameters in acute and subchronic rat models.
    Bahar E; Lee GH; Bhattarai KR; Lee HY; Kim HK; Handigund M; Choi MK; Han SY; Chae HJ; Yoon H
    Drug Des Devel Ther; 2017; 11():2605-2619. PubMed ID: 28919711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxicity Induced by Isoniazid-Lipopolysaccharide through Endoplasmic Reticulum Stress, Autophagy, and Apoptosis Pathways in Zebrafish.
    Zhang Y; Cen J; Jia Z; Hsiao CD; Xia Q; Wang X; Chen X; Wang R; Jiang Z; Zhang L; Liu K
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of hepatoprotective activity of Bacoside to Silymarin treatment against a combined Isoniazid and Rifampin-induced hepatotoxicity in female Wistar rats.
    Sabina EP; Peter S J; S P; Geetha A
    J Histotechnol; 2019 Sep; 42(3):128-136. PubMed ID: 31379302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Inflammatory and Oxidative Stress, Cytochrome P450 2E1, and Bile Acid Disturbance in Rat Liver Injury Induced by Isoniazid and Lipopolysaccharide Cotreatment.
    Hassan HM; Guo H; Yousef BA; Guerram M; Hamdi AM; Zhang L; Jiang Z
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5285-93. PubMed ID: 27324775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of green protic ionic liquids in the crystallization of isoniazid: Evaluation of physicochemical and biological properties of drug.
    Reis CLB; Campelo TA; Frota CC; Ayala AP; Silva LMA; Rocha MVP; Santiago-Aguiar RS
    Eur J Pharm Biopharm; 2024 Aug; 201():114345. PubMed ID: 38823540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of quercetin-phospholipid complex to improve the bioavailability and protection effects against carbon tetrachloride-induced hepatotoxicity in SD rats.
    Zhang K; Zhang M; Liu Z; Zhang Y; Gu L; Hu G; Chen X; Jia J
    Fitoterapia; 2016 Sep; 113():102-9. PubMed ID: 27431774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The food supplement coenzyme Q10 and suppression of antitubercular drug-induced hepatic injury in rats: the role of antioxidant defence system, anti-inflammatory cytokine IL-10.
    Baskaran UL; Sabina EP
    Cell Biol Toxicol; 2015 Oct; 31(4-5):211-9. PubMed ID: 26374116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human volunteer, in vitro, and molecular level evaluation of an optimized taste-masked isoniazid-chitosan spray-dried microparticle matrix.
    Stagner WC; Iyer M; Rathod V; Meruva S; Staton S; Haware RV
    Int J Pharm; 2019 Dec; 572():118774. PubMed ID: 31678392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selected pharmaceutical excipient prevent isoniazid and rifampicin induced hepatotoxicity.
    Shih TY; Ho SC; Hsiong CH; Huang TY; Hu OY
    Curr Drug Metab; 2013 Jul; 14(6):720-8. PubMed ID: 23701163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoniazid and its toxic metabolite hydrazine induce in vitro pyrazinamide toxicity.
    Tostmann A; Boeree MJ; Peters WH; Roelofs HM; Aarnoutse RE; van der Ven AJ; Dekhuijzen PN
    Int J Antimicrob Agents; 2008 Jun; 31(6):577-80. PubMed ID: 18358703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-drug cocrystals of antituberculous 4-aminosalicylic acid: Screening, crystal structures, thermochemical and solubility studies.
    Drozd KV; Manin AN; Churakov AV; Perlovich GL
    Eur J Pharm Sci; 2017 Mar; 99():228-239. PubMed ID: 28011126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.